Press Archive
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Reputable Ophthalmologist Vk Raju, MD, FRCS, FACS, will be Noted in The Leading Physicians of the World
Find an Eye MD near you!
- Details
Medidur, an injectable insert that provides sustained release of flucinolone acetonide for 3 years, helps prevent recurrence of posterior uveitis.
Read more: Sustained-release corticosteroid for uveitis shows promise
- Details
This non-randomized clinical trial assessed the efficacy of 2% ibopamine, a topical drug that temporarily increases aqueous production, for diagnosing glaucoma.
Read more: Ibopamine challenge test can diagnose glaucoma stages
- Details
This retrospective review shows that the introduction of corneal collagen crosslinking may have reduced the number of keratoplasty procedures for keratoconus.
- Details
The FDA has issued a final guidance document for industry and FDA staff on minimally invasive glaucoma surgical (MIGS) devices.
- Details
Ocular Therapeutix announced promising topline results from a phase 2 clinical trial of sustained-released dexamethasone for inflammatory dry eye disease.
Read more: Sustained-released dexamethasone shows promise in dry eye
- Details
Retrospective review shows anti-VEGF treatment should be performed cautiously in patients with retinal angiomatous proliferation (RAP).
Read more: Risk factors for RPE tears after ranibizumab for RAP